YS Biopharma Co Ltd
NASDAQ:LSB

Watchlist Manager
YS Biopharma Co Ltd Logo
YS Biopharma Co Ltd
NASDAQ:LSB
Watchlist
Price: 3.08 USD -8.06% Market Closed
Market Cap: 58.8m USD
Have any thoughts about
YS Biopharma Co Ltd?
Write Note

YS Biopharma Co Ltd
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

YS Biopharma Co Ltd
Accounts Payable Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
YS Biopharma Co Ltd
NASDAQ:LSB
Accounts Payable
ÂĄ67.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Accounts Payable
ÂĄ3.7B
CAGR 3-Years
20%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Accounts Payable
ÂĄ220.6m
CAGR 3-Years
-7%
CAGR 5-Years
30%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Accounts Payable
ÂĄ299.9m
CAGR 3-Years
39%
CAGR 5-Years
32%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Accounts Payable
ÂĄ16.3B
CAGR 3-Years
41%
CAGR 5-Years
47%
CAGR 10-Years
91%
Imeik Technology Development Co Ltd
SZSE:300896
Accounts Payable
ÂĄ44.7m
CAGR 3-Years
113%
CAGR 5-Years
17%
CAGR 10-Years
N/A

See Also

What is YS Biopharma Co Ltd's Accounts Payable?
Accounts Payable
67.8m CNY

Based on the financial report for Mar 31, 2024, YS Biopharma Co Ltd's Accounts Payable amounts to 67.8m CNY.

What is YS Biopharma Co Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 1Y
-16%

Over the last year, the Accounts Payable growth was -16%.

Back to Top